Rivaroxaban for treatment of livedoid vasculopathy: A systematic review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rivaroxaban for treatment of livedoid vasculopathy: A systematic review

Published:2021-07-18 Issue:5 Volume:34 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Gao Yimeng¹^ORCID,Jin Hongzhong¹^ORCID

Affiliation:

1. Department of Dermatology State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases Beijing China

Funder

National Natural Science Foundation of China

National Key Research and Development Program of China

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.15051

Reference24 articles.

1. Quality-of-life impairment in patients with livedoid vasculopathy

2. Livedoid Vasculopathy

3. Treatment for Livedoid Vasculopathy

4. Rivaroxaban - Metabolism, Pharmacologic Properties and Drug Interactions

5. Rivaroxaban prevents painful cutaneous infarctions in livedoid vasculopathy

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Personalized Approaches to Cardiovascular Disease: Insights into FDA-Approved Interventions and Clinical Pharmacogenetics;Current Pharmaceutical Design;2024-06

2. Rivaroxaban in the treatment of livedoid vasculopathy: A long-term retrospective study;JAAD International;2024-03

3. Improvement of Nutritional Status of Patients with Adenomyosis Combined with Lower Extremity Deep Venous Thrombosis by Combination Therapy;Current Topics in Nutraceutical Research;2024-01-06

4. Probable rivaroxaban-induced erythema multiforme in children: A case report;Saudi Pharmaceutical Journal;2023-11

5. Evaluation of the Hemostatic Effect of an Innovative Tissue Adhesive during Extraction Therapy under Rivaroxaban in a Rodent Model;Journal of Functional Biomaterials;2023-06-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3